Velscope - Fluorescence Visualization Technology
Every hour of every day in America someone dies of oral cancer. Oral cancer is the sixth most common diagnosed form of cancer in the United States and presently 30,000 patients are diagnosed annually. The 5-year survival rate is only 50%, accounting for 8,000 deaths each year.
Oral Cancer risk factors include tobacco use, frequent and/or excessive alcohol consumption, a compromised immune system, past history of cancer, and the presence of the HPV virus. Recently, however, 25% of all newly diagnosed cases have been in patients under the age of forty with none of the known risk factors. Oral Cancer survival rate has not improved in the past 50 years, primarily due to the fact we have not changed the way we screen for this disease (a visual and manual examination of the oral cavity, head, and neck).
The VELscope System is a revolutionary hand-held device that provides dentists, hygienists and other oral health care professionals with an easy-to-use examination system for the early detection of abnormal oral tissue. The Oral Cancer examination using VELscope is painless, noninvasive, and does not use rinses or stains. It only takes one to two minutes. The VELscope System Handpiece emits a safe blue light into the oral cavity causing it to fluoresce. The clinician then differentiates between normal and abnormal tissue, and is approved by the Federal Drug Administration (FDA).